Ardea Biosciences' IPO

Ardea Biosciences raised a round of funding on March 06, 2000. Investors include Public.

Ardea Biosciences is focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV).…

Articles about Ardea Biosciences' IPO: